In this March 31, 2020 file photo, a woman pulls groceries from a cart to her vehicle outside of a Walmart store in Pearl, Miss. Walmart is teaming with the General Motors' Cruise autonomous vehicle unit to test automated package delivery in Arizona. (AP Photo/Julio Cortez, File)
By Michael Balsamo and Ann D'Innocenzio
The Justice Department is suing Walmart, alleging the company unlawfully dispensed controlled substances through its pharmacies, helping to fuel the opioid crisis in America.
The civil complaint being filed Tuesday points to the role Walmart’s pharmacies may have played in the crisis by filling opioid prescriptions and by unlawfully distributing controlled substances to the pharmacies during the height of the opioid crisis. Walmart operates more than 5,000 pharmacies in its stores around the country.
The Justice Department alleges Walmart violated federal law by selling thousands of prescriptions for controlled substances that its pharmacists “knew were invalid,” said Jeffrey Clark, the acting assistant attorney general in charge of the Justice Department’s civil division.
Federal law required Walmart to spot suspicious orders for controlled substances and report those to the Drug Enforcement Administration, but prosecutors charge the company didn’t do that. Walmart couldn’t immediately be reached for comment.
“Walmart knew that its distribution centers were using an inadequate system for detecting and reporting suspicious orders,” said Jason Dunn, the U.S. attorney in Colorado. “As a result of this inadequate system, for years Walmart reported virtually no suspicious orders at all. In other words, Walmart’s pharmacies ordered opioids in a way that went essentially unmonitored and unregulated.”
The suit alleges that Walmart made it difficult for its pharmacists to follow the rules, putting “enormous pressure" on them to fill a high volume of prescriptions as fast as possible, while at the same time denying them the authority to categorically refuse to fill prescriptions issued by prescribers the pharmacists knew were continually issuing invalid prescriptions.
AP reported the news of the lawsuit ahead of the Justice Department's public announcement, citing a person who could not discuss the matter publicly before the announced move. The person spoke to the AP on condition of anonymity.
The Justice Department’s lawsuit comes nearly two months after Walmart filed its own preemptive suit against the Justice Department, Attorney General William Barr, and the Drug Enforcement Administration.
In its lawsuit, Walmart said the Justice Department’s investigation — launched in 2016 — had identified hundreds of doctors who wrote problematic prescriptions that Walmart’s pharmacists should not have filled. But the lawsuit charged that nearly 70% of the doctors still have active registrations with the DEA.
Walmart’s lawsuit alleged the government was blaming it for the lack of regulatory and enforcement policies to stem the crisis. The company is asking a federal judge to declare the suit has no basis to seek civil damages. That suit remains ongoing.
The initial investigation was the subject of a ProPublica story published in March. ProPublica reported that Joe Brown, then U.S. attorney for the Eastern District of Texas office, spent years pursuing a criminal case against Walmart for its opioid prescription practices, only to have it stymied after the retail giant’s lawyers appealed to senior officials in the Justice Department.
Two months later, Brown resigned. He didn’t give a reason for his departure except to say he would be “pursuing opportunities in the private and public sectors." Brown went into private practice in the Dallas area.
Updated on December 22, 2020, at 3:44 p.m. ET with additional details.
Treasury officials say that filing taxes this year could be frustrating due to staffing shortages at the IRS and paperwork backlog. Cheddar News speaks with Brent Weiss, certified financial planner and co-founder of Facet Wealth, on how to best file your returns in 2022.
As the need for COVID-19 testing increases, so does the price of the tests themselves. An agreement with The White House and several major companies to sell the tests at a lower cost has now expired, sending prices up as retailers struggle to keep kits on shelves. Dr. Thomas McGinn, executive VP of physician enterprise at Common Spirit Health, joins Cheddar News to discuss.
With no end in sight to supply chain snarls, some companies are reconsidering the way they manufacture goods. Harry Moser, founder and president of Reshoring Initiative and Jennifer Smith, logistics and supply chain reporter for the Wall Street Journal, joined Cheddar News' Closing Bell to discuss some of the ways companies are trying to solve their supply chain problems in the long term.
Stocks closed higher Tuesday with the tech-heavy Nasdaq rising for a second straight day as tech stocks rebound. Investors also felt some relief after Federal Reserve Chair Jerome Powell today said the central bank is prepared to raise interest rates 'more over time' if inflation continues to run hot. Ross Mayfield, investment strategy analyst at Baird, joins Cheddar News' Closing Bell to discuss today's market close, whether and how markets are pricing in Fed activity, and more.
Bitcoin dipped below $40,000 this week amid a broader slump to begin the year. Some speculate that as cryptocurrencies correlate closer to traditional assets that factors like the Federal Reserve tightening monetary policy will weigh on digital coins. Jalak Jobanputra, managing partner at Future Perfect Ventures, joins Cheddar News' Closing Bell to discuss why crypto markets are feeling pressure from the Fed's potential 2022 rate hikes, broader crypto market predictions, and more.
A.I. startup Fractal has raised $360 million in funding, officially entering the unicorn club. Pranay Agrawal, CEO and Co-Founder of Fractal, joined Cheddar News' Closing Bell to discuss what the company plans to do with the fresh capital.
Electric vehicles are quickly becoming an accessible way for consumers to slash emissions as legacy automakers begin to electrify their fleets and world leaders including President Joe Biden push for broad EV adoption. But consumers have concerns about EV range, the availability of charging stations, and more. What if it were both helpful to consumers — and feasible from a climate change standpoint — to keep hybrid models that run on gas on the market? Gill Pratt, CEO of the Toyota Research Institute & Toyota Motor Corporation's Chief Scientist joins Cheddar Climate to discuss his team's research about 'carbon return on investment,' how Toyota is electrifying its fleet, and more.
Fresh off of a $42 million Series B Fundraise, co-founder and CEO of Chapter, Cobi Blumenfeld-Gantz, joined Cheddar to discuss the company's business model and how it will use the capital going forward. He explained that Chapter is a Medicare advisor that searches savings on medical options in order to help users find the right plan for them. "We want to make sure we can help all of our existing members and as many new Americans find the right Medicare coverage, so we're hiring aggressively for the best talent we can," Blumenfeld-Gantz said.
Apple's iMessage has come under fire after a Google executive accused the fellow tech giant of bullying — Android Users. Hiroshi Lockheimer, Google SVP of Android, said that Apple's lack of RCS adoption is holding the industry back while the company uses peer pressure to bolster iMessage.
